| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 210.01B | 209.84B | 234.23B | 243.48B | 193.39B | 181.36B |
| Gross Profit | 19.09B | 18.59B | 16.74B | 13.16B | 13.70B | 13.58B |
| EBITDA | 8.18B | 8.00B | 7.46B | 4.14B | 7.21B | 8.76B |
| Net Income | 3.73B | 3.50B | 3.33B | 827.00M | 3.21B | 3.78B |
Balance Sheet | ||||||
| Total Assets | 99.26B | 101.58B | 103.82B | 97.59B | 88.01B | 87.93B |
| Cash, Cash Equivalents and Short-Term Investments | 7.89B | 11.94B | 3.01B | 1.96B | 4.75B | 11.75B |
| Total Debt | 8.02B | 9.88B | 7.63B | 12.37B | 4.12B | 7.10B |
| Total Liabilities | 31.45B | 34.06B | 38.16B | 36.18B | 25.85B | 27.66B |
| Stockholders Equity | 67.72B | 67.42B | 65.57B | 61.18B | 61.94B | 59.61B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.62B | 6.54B | -10.09B | -5.14B | 2.62B |
| Operating Cash Flow | 0.00 | 11.99B | 10.37B | -6.48B | -2.47B | 5.28B |
| Investing Cash Flow | 0.00 | -3.83B | -4.57B | -3.56B | 468.00M | -1.55B |
| Financing Cash Flow | 0.00 | 772.00M | -4.76B | 7.24B | -5.03B | 272.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥64.28B | 8.46 | ― | 3.63% | 1.78% | 19.50% | |
73 Outperform | ¥43.47B | 5.92 | 11.01% | 3.97% | -5.05% | -16.39% | |
69 Neutral | ¥182.79B | 9.91 | 12.56% | 3.44% | 3.80% | 63.03% | |
69 Neutral | ¥22.48B | 2.45 | ― | 2.54% | 2.80% | 154.89% | |
67 Neutral | ¥65.16B | 20.57 | ― | 3.77% | -3.91% | -25.32% | |
63 Neutral | ¥52.65B | 7.68 | ― | 3.25% | -4.39% | -13.20% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |